Nuevos aspectos terapéuticos en el Cáncer de Pulmón EGFR mutado

Previous Page

Next Page

Page Background

Global cancer survival 2000-2014 CONCORD 3

Lung cancer 5-year survival rate

www.thelancet.com

Published online January 30, 2018

http://dx.doi.org/10.1016/S0140-6736

(17)33326-3

2000-2004

2005-2009

2010-20014